Evidence map›Paper›PMID 41586967›Full record

ArticleInternational urology and nephrology2026

Effect of frailty status and histopathological features on upstaging of non-muscle-invasive bladder cancer: a critical analysis based on machine learning.

Sami Berk Özden, Emre Bulbul, Yavuz İlki, Ahmet Vural, Admir Ozturk, Cetin Demirdag, Sinharib Citgez

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sami Berk ÖzdenDepartment of Urology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Kocamustafapaşa Cd. No: 53, Fatih, 34098, Istanbul, Turkey. s.berkozden@gmail.com.
Emre BulbulDepartment of Urology, Trabzon Vakfıkebir State Hospital, Trabzon, Turkey.
Yavuz İlkiDepartment of Urology, Gülhane Training and Research Hospital, Ankara, Turkey.
Ahmet VuralDepartment of Urology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Kocamustafapaşa Cd. No: 53, Fatih, 34098, Istanbul, Turkey.
Admir OzturkDepartment of Urology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Kocamustafapaşa Cd. No: 53, Fatih, 34098, Istanbul, Turkey.
Cetin DemirdagDepartment of Urology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Kocamustafapaşa Cd. No: 53, Fatih, 34098, Istanbul, Turkey.
Sinharib CitgezDepartment of Urology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Kocamustafapaşa Cd. No: 53, Fatih, 34098, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis study aimed to develop a machine learning (ML)-assisted model to predict the risk of upstaging (subsequent higher stage on repeat pathology) in non-muscle-invasive bladder cancer (NMIBC).

methodsA retrospective cohort study was conducted on 380 patients with NMIBC. Comprehensive data on demographics, comorbidities, frailty (modified frailty index, mFI), nutritional status (nutritional risk index, NRI), inflammatory indices, and detailed histopathological features were collected. The primary outcome was pathological upstaging, defined as a diagnosis of a higher T stage (from Ta to ≥ T1 or from T1 to ≥ T2) on a subsequent procedure. Multivariate logistic regression and six machine learning models were developed and evaluated using tenfold cross-validation, and their performances in predicting upstaging were directly compared.

resultsPathological upstaging occurred in 84 patients (22.1%). Multivariate logistic regression identified initial T1 stage (OR: 13.54), high tumor grade (OR: 4.60), lymphovascular invasion (LVI) (OR: 3.67), frailty (mFI ≥ 2, OR: 2.68), and lower estimated glomerular filtration rate (eGFR) as factors independently associated with upstaging (AUC: 0.702). Machine learning models, particularly the support vector machine (SVM), demonstrated superior predictive performance (AUC: 0.796). Analysis using supervised learning algorithms confirmed tumor grade as the strongest associated factor, followed by initial T stage, the presence of lymphovascular invasion on initial TURBT (transurethral resection of the bladder tumor), frailty, eGFR, and occupational exposure.

conclusionsThis study demonstrates that artificial intelligence models provide a superior framework for predicting subsequent pathological upstaging in NMIBC compared to traditional multivariate logistic regression. The ML-driven analysis adequately validated established clinical risk factors associated with upstaging. Among all variables evaluated, high tumor grade emerged as the most powerful and clinically significant factor associated with upstaging. Thus, ML-assisted tools may feasibly be integrated into clinical practice to enhance risk stratification.

Indexed as

FrailtyMachine LearningNon-Muscle Invasive Bladder NeoplasmsUrinary Bladder NeoplasmsAgedAged, 80 and overCohort StudiesFemaleHumansMaleMiddle AgedNeoplasm InvasivenessNeoplasm StagingPredictive Learning ModelsRetrospective StudiesFrailtyMachine learningNon-muscle-invasive bladder cancerUpstaging

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.